使用乳腺癌患者考虑进行乳腺重建的决策辅助器共享决策:在日本进行集群随机对照试验的研究协议
Yoshihiro Sowa1, Wakako Osaka2, Itaru Tsuge3
1Department of Plastic Surgery, Jichi Medical University, Shimotsuke, Japan ysowawan@gmail.com.
BMJ open
|October 7, 2025
概括
这项研究调查了决策辅助工具是否能改善日本乳房重建的共享决策. 这些发现旨在加强患者的支持,并减少癌症护理中的决策冲突.
科学领域:
- 在瘤学瘤学.
- 医疗保健服务研究 医疗服务研究
- 决策科学 决策科学 决策科学
背景情况:
- 共享决策 (SDM) 对于患者的自主性至关重要,但在日本欠发达,特别是在乳房重建方面.
- 决策辅助 (DA) 是SDM的重要工具,但与西方国家相比,日本对乳房重建的实施落后.
- 日本独特的文化和医疗背景需要对SDM与DA在乳房重建决策中的实用性进行调查.
研究的目的:
- 为了评估SDM的临床有效性,使用DA用于考虑重建的乳腺癌患者.
- 评估DA对乳房重建患者决策冲突和术后生活质量的影响.
- 确定SDM与DA在日本特定的医疗保健环境中的可行性和实用性.
主要方法:
- 一个多中心,集群随机对照试验,涉及12个由日本乳腺瘤外科协会认证的设施.
- 包括年龄≥20岁的新诊断的乳腺癌0-III期的女性患者,对乳腺重建感兴趣.
- 主要结果评估使用决策冲突尺度来衡量DA在减少冲突和遗憾方面的有效性.
主要成果:
- 该研究旨在评估决策辅助工具在减少决策冲突和遗憾方面的有效性.
- 术后生活质量将被评估为一个关键的次要结果.
- 数据收集包括在基线和随访时进行患者调查和医疗记录审查.
结论:
- 预计这些发现将澄清SDM使用DA用于日本乳房重建的临床有效性.
- 这项研究有可能改善乳腺癌护理的决策过程和患者结果.
- 通过出版物和全国会议传播将推动医学决策科学,并可能减少健康差异.
相关概念视频
01:13Randomized Experiments
6.3K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
6.3K
01:11Bioavailability Study Design: Single Versus Multiple Dose Studies
383
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
383
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
248
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
248
01:20Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
407
Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
407
01:21Cancer Survival Analysis
863
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
863